Popular on s4story
- Dr. Stewart Nozette Releases New Techno-Thriller The Day of Infamy – Space Pearl Harbor - 150
- For International Joke Day: Wanna Tickle that Funny Bone? Check out "Crazy Robert's Joke Book" - 126
- Sara Abbas Receives "Eniochos" Charioteer Award at 2026 Who is Who International Awards - 105
- Sylvester Anthony III Introduces His Artist Journey with Debut Single "Cherish"
- SUN Automation Group and KOLBUS America Align Hycorr Parts Support to Enhance Customer Service
- The Story Tree Literacy Project Seeks Publishers and Librarians to Help Children Become Polyglots
- Disruptor Creations Pioneers New MicroAdventure Series with TravelSpike
- Kasinohai Audit: Most Slots Could Be Affected by Finland's Draft Gambling Rules
- Talentica Software Earns a Place Among India's Top 100 Great Mid-size Workplaces 2026
- IGH Naturals Announces Peer-Reviewed HuMOLYTE® Study Published in Frontiers in Nutrition
Similar on s4story
- Aderra Opens in Magnolia, Texas, Offering a New Model for 62+ Homeownership
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
- U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
- Missouri Hemp Businesses File Federal Lawsuit Challenging HB 2641
- CCHR: Congressional Hearing Revives Lessons from MKULTRA Era – Why Past Psychiatric Human Rights Abuses Demand Vigilance Today
- Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
- Lineus Medical Renews Agreement with Vizient, Delivering Enhanced Value for Vizient Members
- Qscription Technologies Appoints Radiology Industry Veteran Elliot Silverman to Advisory Board
- Mr. Hospital Bed Helps Home Care Buyers Find the Right Hospital Bed
- World Cup Crowds Are a Stress Test for America's Restrooms
Dosi Announces the World's Most Capable Peptide, GLP-1 and TRT Tracking App
S For Story/10698555
Available internationally through the Apple App Store and Google Play, Dosi brings 180+ compound profiles, personal tracking, injection-site history, a reconstitution calculator, and the Ask Dosi intelligence layer in one mobile platform.
ST. AUGUSTINE, Fla. - s4story -- Dosi, a Health & Fitness app from 3WB Holdings, announced mobile availability on iOS and Android. Built as the world's most capable peptide tracker and personal protocol organizer, Dosi gives people managing complex routines one place for their schedules, logs, reference material, and routine history.
Dosi is available internationally through the Apple App Store and Google Play. Its current public product listings describe features including personal dose logging, schedules and reminders, a body-map record for injection-site rotation, a reconstitution calculator, protocol history, and a 180+ compound reference library.
The platform is designed around personal tracking and educational reference across routine categories represented in Dosi's current public materials, including GLP-1, TRT, HRT, fertility and IVF medication, peptides, growth-hormone routines, nootropics, and longevity-related compounds. For people organizing GLP-1 routines, the app can serve as a semaglutide tracker or tirzepatide tracker. Category coverage is not a medical recommendation, suitability determination, or treatment guidance.
More on S For Story
Dosi also includes Ask Dosi, an in-app AI intelligence layer described in its current store listings as a research-informed information feature. Ask Dosi is intended to help users find relevant educational and tracking information inside the product; it is not a clinician, does not diagnose or prescribe, and is not a substitute for qualified healthcare guidance.
"People managing complex routines often end up moving between calendars, notes, screenshots, and spreadsheets," said Dean White, Founder and CEO of Dosi. "We built Dosi to give them one place to organize the information they personally track and bring better context to conversations with their qualified healthcare providers."
Dosi's free tier allows users to start organizing a protocol. Premium plans add expanded product features. The app is intended for informational and organizational use only; it does not provide medical advice, diagnosis, or treatment. Users should consult a qualified healthcare provider regarding medical decisions, prescriptions, dosing, or treatment.
More on S For Story
About Dosi: Dosi is a personal protocol-tracking app for iOS and Android, built by 3WB Holdings in St. Augustine, Florida.
Media Contact: Dosi / 3WB Holdings — press@heydosi.com
Website: https://heydosi.com
Press kit: Dosi Press (https://heydosi.com/en/press?utm_source=prlog&utm_medium=press_release&utm_campaign=dosi_cross_platform_availability_2026_07)
Dosi is available internationally through the Apple App Store and Google Play. Its current public product listings describe features including personal dose logging, schedules and reminders, a body-map record for injection-site rotation, a reconstitution calculator, protocol history, and a 180+ compound reference library.
The platform is designed around personal tracking and educational reference across routine categories represented in Dosi's current public materials, including GLP-1, TRT, HRT, fertility and IVF medication, peptides, growth-hormone routines, nootropics, and longevity-related compounds. For people organizing GLP-1 routines, the app can serve as a semaglutide tracker or tirzepatide tracker. Category coverage is not a medical recommendation, suitability determination, or treatment guidance.
More on S For Story
- CRG Awarded NASA SEWP VI Contracts in Categories B and C
- Heidi G. Villari of The Villari Firm, PLLC Named to Super Lawyers for the Tenth Consecutive Year
- The Legacy Table: A Celebration of Faith, Family & Legacy
- Patriotic poem selected for E pluribus unum anthology
- Elevate Your Sneakers With Crep Protect Trek Laces
Dosi also includes Ask Dosi, an in-app AI intelligence layer described in its current store listings as a research-informed information feature. Ask Dosi is intended to help users find relevant educational and tracking information inside the product; it is not a clinician, does not diagnose or prescribe, and is not a substitute for qualified healthcare guidance.
"People managing complex routines often end up moving between calendars, notes, screenshots, and spreadsheets," said Dean White, Founder and CEO of Dosi. "We built Dosi to give them one place to organize the information they personally track and bring better context to conversations with their qualified healthcare providers."
Dosi's free tier allows users to start organizing a protocol. Premium plans add expanded product features. The app is intended for informational and organizational use only; it does not provide medical advice, diagnosis, or treatment. Users should consult a qualified healthcare provider regarding medical decisions, prescriptions, dosing, or treatment.
More on S For Story
- Bruce Goldwell Announces The Tesla Codex
- Meet Privateer: Tucson's High-Tech Security Force Built With Paramilitary Precision
- NovaSeed: Eden Archive —Hard Science Fiction Mars Colonization Saga Now Available, Official Series
- Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
About Dosi: Dosi is a personal protocol-tracking app for iOS and Android, built by 3WB Holdings in St. Augustine, Florida.
Media Contact: Dosi / 3WB Holdings — press@heydosi.com
Website: https://heydosi.com
Press kit: Dosi Press (https://heydosi.com/en/press?utm_source=prlog&utm_medium=press_release&utm_campaign=dosi_cross_platform_availability_2026_07)
Source: Dosi / 3WB Holdings
0 Comments
Latest on S For Story
- Lionheart Holdings and KEO Energy Sign Letter of Intent for Proposed Business Combination
- Marcus Christ Announces Singles: "The Hammer Goes Click" and "You Hate Me, I Hate You"
- Do Football Coaches Overthink Things?
- Fatal FOMO May be Your Last Roll of the Dice
- Book On Shelves Launches to Help Independent and Self-Published Authors Get Their Books
- ASWIFTT BOOKS released "Inspirational Quotes Vol. II
- Book 'Elephants In The Room' Published by Speaking Volumes
- Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board
- Theresa Zaino Featured on "We Got Your 6 @ 6:00" with Host Mark E. Petersen
- Absinthia Previews The Green Fairy's Canvas at Tales of the Cocktail, Announces Upcoming Kickstarter
- Prince George's County MWA Hosts Fiction Craft Event on Conflict and Suspense with Austin Camacho
- Allstream Energy Partners Returns as a Media Partner for the 2026 API Inspection & Mechanical Integrity Summit in San Antonio
- The Moment After Death: New Novel Reveals What Happens After We Die - Backed by CIA Documents
- On Mandela Day, A Harlem Debate Asks: Is Nelson Mandela One Of History's Greatest Innovators?
- New Book - The Character of Freedom: The Scottish Enlightenment and American Slavery
- PokerStars & Ladbrokes veteran buys into Finnish news media Rahapelisanomat
- Former Judge Chris Oldner Honored as Best Lawyer by "D Magazine" for 6th Straight Year
- Missouri Hemp Businesses File Federal Lawsuit Challenging HB 2641
- SUN Automation Group and KOLBUS America Align Hycorr Parts Support to Enhance Customer Service
- Boston Industrial Solutions Launches New Citrine® SA1-370 Silicone Glue for Permanent Adhesion